The burden of Parkinson disease (PD) and concomitant comorbidities

Archives of Gerontology and Geriatrics

Volumn 49, Issue 2, 2009, Pages 317-321

  Pohar, Sheri L ^a   Allyson Jones, C ^b  

^a INSTITUTE OF HEALTH ECONOMICS   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Health survey; Parkinson disease; Quality of life

Indexed keywords

AGED; ANALYSIS OF COVARIANCE; ARTHRITIS; ARTICLE; CANADA; COMMUNITY LIVING; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; DEMOGRAPHY; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PARKINSON DISEASE; PRIORITY JOURNAL; SAMPLE SIZE; SCORING SYSTEM; SOCIAL ASPECT; URINE INCONTINENCE;

ADULT; AGED; CANADA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; QUALITY OF LIFE;

EID: 67649742607     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2008.11.006     Document Type: Article

References (31)

1. Aarsland D., Larsen J.P., Tandberg E., and Laake K. Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study. J. Am. Geriatr. Soc. 48 (2000) 938-942
2. Aarsland D., Zaccai J., and Brayne C. A systematic review of prevalence studies of dementia in Parkinson's disease. Mov. Disord. 20 (2005) 1255-1263
3. Beland Y. Canadian community health survey-methodological overview. Health Rep. 13 (2002) 9-14
4. Chrischilles E.A., Rubenstein L.M., Voelker M.D., Wallace R.B., and Rodnitzky R.L. The health burdens of Parkinson's disease. Mov. Disord. 13 (1998) 406-413
5. Cordato D.J., Schwartz R., Abbott E., Saunders R., and Morfis L. A comparison of health-care costs involved in treating people with and without Parkinson's disease in Southern Sydney, New South Wales, Australia. J. Clin. Neurosci. 13 (2006) 655-658
6. Damiano A.M., Snyder C., Strausser B., and Willian M.K. A review of health-related quality-of-life concepts and measures for Parkinson's disease. Qual. Life Res. 8 (1999) 235-243
7. Dodel R.C., Berger K., and Oertel W.H. Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: impact of motor fluctuations and dyskinesias. Pharmacoeconomics 19 (2001) 1013-1038
8. Dowding C.H., Shenton C.L., and Salek S.S. A review of the health-related quality of life and economic impact of Parkinson's disease. Drugs Aging 23 (2006) 693-721
9. Feeny D., Furlong W., Torrance G.W., Goldsmith C.H., Zhu Z., Depauw S., Denton M., and Boyle M. Multiattribute and single-attribute utility functions for the Health Utilities Index Mark 3 system. Med. Care 40 (2002) 113-128
10. Global Parkinson's Disease Survey Steering Committee. Factors impacting on quality of life in Parkinson's disease: results from an international survey. Mov. Disord. 17 (2002) 60-67
11. Grootendorst P., Feeny D., and Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med. Care 38 (2000) 290-299
12. Hobson P., Holden A., and Meara J. Measuring the impact of Parkinson's disease with the Parkinson's Disease Quality of Life questionnaire. Age Ageing 28 (1999) 341-346
13. Horsman J., Furlong W., Feeny D., and Torrance G. The Health Utilities Index (HUI(R)): concepts, measurement properties and applications. Health Qual. Life Outcomes 1 (2003) 54-66
14. Jenkinson C., Fitzpatrick R., Peto V., Greenhall R., and Hyman N. The Parkin-son's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 26 (1997) 353-357
15. Jenkinson C., Fitzpatrick R., and Peto V. Health-related quality-of-life measurement in patients with Parkinson's disease. Pharmacoeconomics 15 (1999) 157-165
16. Karlsen K.H., Larsen J.P., Tandberg E., and Maeland J.G. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 66 (1999) 431-435
17. Karlsen K.H., Tandberg E., Arsland D., and Larsen J.P. Health related quality of life in Parkinson's disease: a prospective longitudinal study. J. Neurol. Neurosurg. Psychiatry 69 (2000) 584-589
18. Leibson C.L., Maraganore D.M., Bower J.H., Ransom J.E., O'Brien P.C., and Rocca W.A. Comorbid conditions associated with Parkinson's disease: a population-based study. Mov. Disord. 21 (2006) 446-455
19. Levy G., Tang M.X., Louis E.D., Cote L.J., Alfaro B., Mejia H., Stern Y., and Marder K. The association of incident dementia with mortality in PD. Neurology 59 (2002) 1708-1713
20. Maddigan S.L., Feeny D.H., and Johnson J.A. A comparison of the Health Utilities Indices Mark 2 and Mark 3 in type 2 diabetes. Med. Decis. Making 23 (2003) 489-501
21. Maddigan S.L., Feeny D.H., and Johnson J.A. Construct validity of the RAND-12 and Health Utilities Index Mark 2 and Mark 3 in type 2 diabetes. Qual. Life Res. 13 (2004) 435-448
22. Maddigan S.L., Feeny D.H., and Johnson J.A. Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey. Qual. Life Res. 14 (2005) 1311-1320
23. Noyes K., Liu H., Li Y., Holloway R., and Dick A.W. Economic burden associated with Parkinson's disease on elderly Medicare beneficiaries. Mov. Disord. 21 (2006) 362-372
24. Riazi A., Hobart J.C., Lamping D.L., Fitzpatrick R., Freeman J.A., Jenkinson C., Peto V., and Thompson A.J. Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles. J. Neurol. Neurosurg. Psychiatry 74 (2003) 710-714
25. Rubenstein L.M., Chrischilles E.A., and Voelker M.D. The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey. Pharmacoeconomics 12 (1997) 486-498
26. Rubenstein L.M., Voelker M.D., Chrischilles E.A., Glenn D.C., Wallace R.B., and Rodnitzky R.L. The usefulness of the Functional Status Questionnaire and Medical Outcomes Study Short Form in Parkinson's disease research. Qual. Life Res. 7 (1998) 279-290
27. Schrag A., Jahanshahi M., and Quinn N. How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population. Mov. Disord. 15 (2000) 1112-1118
28. Schrag A., Jahanshahi M., and Quinn N. What contributes to quality of life in patients with Parkinson's disease? J. Neurol. Neurosurg. Psychiatry 69 (2000) 308-312
29. Siderowf A., Ravina B., and Glick H.A. Preference-based quality-of-life in patients with Parkinson's disease. Neurology 59 (2002) 103-108
30. Statistics Canada, 2004. CCHS Cycle 1.1. Public Use Microdata File Documentation.
31. Svenson L.W., Platt G.H., and Woodhead S.E. Geographic variations in the prevalence rates of Parkinson's disease in Alberta. Can. J. Neurol. Sci. 20 (1993) 307-311